Fundraising Fox

Checkpoint Surgical

Cleveland, US · Founded 2009 · Delaware corporation · 5 known investors

checkpointsurgical.com

Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.

BiotechHealthtechMedical Devices

Founders & leadership

MA
Marilyn A. EiseleExecutive
KM
Kevin M. ScanlanExecutive
DH
Donald HubbardExecutive
MS
Mark StultzNamed on SEC filing
LC
Leonard CosentinoNamed on SEC filing
GT
Geoffrey ThropeNamed on SEC filing
SZ
Scott ZeilingerNamed on SEC filing
ME
Marilyn EiseleNamed on SEC filing

Board

TMTracy Marshbanks
Tracy MarshbanksinBoard directorManaging Director at First Analysis
GBGeoffrey B. Thrope
Geoffrey B. ThropeBoard directorFounder and CEO at NDI
LMLeonard M. Cosentino
Leonard M. CosentinoBoard directorInvestor at NDI

Investors · 5

Reported raises · per SEC filings

Form D private placements

$42.7M disclosed across 6 rounds · 2011–2024

$4MraisedJun 2024 · 42 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ChuisanoDirector
  • Tracy MarshbanksDirector
  • Carter McNabbDirector
  • Derek LewisExecutive Officer, Director
  • Geoffrey ThropeDirector
  • Wayne WallaceDirector
  • Raymond RackleyDirector
Offering amount
$4M
Amount sold
$4M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$13MraisedJun 2021 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Leonard M. CosentinoExecutive Officer, Director
  • Carter McNabbDirector
  • Geoffrey B. ThropeExecutive Officer, Director
  • Raymond RackleyDirector
  • Wayne WallaceDirector
  • Tracy MarshbanksDirector
  • Donald HubbardExecutive Officer
  • Michael ChuisanoDirector
  • Laura KeckExecutive Officer
  • Kevin M. ScanlanExecutive Officer
  • Derek LewisExecutive Officer
  • Richard DiBlasiExecutive Officer
Offering amount
$16M
Amount sold
$13M
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.9MraisedMay 2020 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin M. ScanlanExecutive Officer
  • Laura KeckExecutive Officer
  • Leonard M. CosentinoExecutive Officer, Director
  • Geoffrey B. ThropeExecutive Officer, Director
  • Richard DiBlasiExecutive Officer
  • Tracy MarshbanksDirector
  • Donald HubbardExecutive Officer
  • Michael ChuisanoDirector
  • Raymond RackleyDirector
  • Wayne WallaceDirector
  • Derek LewisExecutive Officer
Offering amount
$5M
Amount sold
$1.9M
Minimum investment
$25K
First sale
May 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.8MraisedSep 2018 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Raymond RackleyDirector
  • Leonard M. CosentinoExecutive Officer, Director
  • Kevin M. ScanlanExecutive Officer
  • Geoffrey B. ThropeExecutive Officer, Director
  • Tracy MarshbanksDirector
  • Wayne WallaceDirector
  • Laura KeckExecutive Officer
  • Richard DiBlasiExecutive Officer
  • Donald HubbardExecutive Officer
Offering amount
$9M
Amount sold
$8.8M
Minimum investment
$10K
Sales commissions
$100K
Placement agents
Beech Hill Securities, Inc.
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7.5MraisedNov 2015 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tracy MarshbanksDirector
  • Geoffrey B. ThropeExecutive Officer, Director
  • Leonard M. CosentinoExecutive Officer, Director
  • Marilyn A. EiseleExecutive Officer
  • Kevin M. ScanlanExecutive Officer
  • Donald HubbardExecutive Officer
Offering amount
$9.5M
Amount sold
$7.5M
Minimum investment
$25K
Sales commissions
$350K
Placement agents
Beech Hill Securities, Inc.
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7.5MraisedJul 2014 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark StultzExecutive Officer
  • Leonard CosentinoExecutive Officer, Director
  • Donald HubbardExecutive Officer, Director
  • Geoffrey ThropeExecutive Officer, Director
  • Scott ZeilingerDirector
  • Marilyn EiseleExecutive Officer
Offering amount
$10M
Amount sold
$7.5M
Minimum investment
$9.2K
First sale
May 2011
Incorporated
Limited Liability Company, Ohio, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Checkpoint Surgical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Checkpoint Surgical do?
Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.
Who are Checkpoint Surgical's investors?
Checkpoint Surgical's investors include First Analysis, Jumpstart Ventures, Mutual Capital Partners, NDI, RC Capital.
How much funding has Checkpoint Surgical raised?
Checkpoint Surgical has disclosed $42.7M raised across 6 rounds.
Where is Checkpoint Surgical headquartered?
Checkpoint Surgical is headquartered in Cleveland, US.